Investing risk healthcare stocks posted steady gains

Healthcare stocks posted steady gains as biotech breakthroughs were announced. Despite optimism, trial-phase risks remind investors of the inherent volatility and investing risk in pharma innovation. In the last twelve months, the biggest single purchase by an insider was when Independent Director Brett Paschke bought US$91k worth of shares at a price of US$1.81 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$4.02. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price. Why invest: These mutual funds will pay out cash interest on a regular schedule, typically monthly. Unlike a CD, a money market fund is liquid, which means you typically can take out your funds at any time without being penalized. Semiconductor indices surged 3% on strong demand forecasts, but supply chain fragility remains a significant investing risk, especially if geopolitical trade disputes escalate.